Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy

AIM: To assess the efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus (T2DM) and established atherosclerotic cardiovascular disease (ASCVD) inadequately controlled by insulin. MATERIALS AND METHODS: VERTIS CV was the cardiovascular outcome study for ertugliflozin. Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Lingvay, Ildiko, Greenberg, Michelle, Gallo, Silvina, Shi, Harry, Liu, Jie, Gantz, Ira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252001/
https://www.ncbi.nlm.nih.gov/pubmed/33769675
http://dx.doi.org/10.1111/dom.14385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252001/
https://www.ncbi.nlm.nih.gov/pubmed/33769675
http://dx.doi.org/10.1111/dom.14385

Ejemplares similares